Provided by Tiger Trade Technology Pte. Ltd.

vTv Therapeutics

31.66
+2.649.10%
Volume:20.08K
Turnover:625.28K
Market Cap:124.68M
PE:-9.39
High:32.62
Open:28.98
Low:28.98
Close:29.02
52wk High:44.00
52wk Low:14.00
Shares:3.94M
Float Shares:2.84M
Volume Ratio:0.63
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3732
EPS(LYR):-3.1991
ROE:-64.17%
ROA:-26.12%
PB:5.85
PE(LYR):-9.90

Loading ...

Analysts Are Bullish on These Healthcare Stocks: vTv Therapeutics (VTVT), Acumen Pharmaceuticals (ABOS)

TIPRANKS
·
Feb 03

vTv Therapeutics expanded its license agreement with Newsoara Biopharma

TIPRANKS
·
Feb 02

vTv Therapeutics Inc - Amended License Includes $50 Mln Development and $65 Mln Sales Milestones

THOMSON REUTERS
·
Feb 02

vTv Therapeutics Inc - to Receive $20 Mln Upfront Payment From Newsoara

THOMSON REUTERS
·
Feb 02

vTv Therapeutics Amends License Agreement With Newsoara Biopharma Co. Ltd. for Pde4 Inhibitor, HPP737

THOMSON REUTERS
·
Feb 02

vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737

GlobeNewswire
·
Feb 02

vTv Therapeutics Inc : Btig Raises Target Price to $49 From $40

THOMSON REUTERS
·
Jan 27

vTv Therapeutics Is Maintained at Buy by BTIG

Dow Jones
·
Jan 27

Analysts’ Top Healthcare Picks: OKYO Pharma Limited Sponsored ADR (OKYO), vTv Therapeutics (VTVT)

TIPRANKS
·
Jan 24

vTv Therapeutics Initiated at Buy by Roth Capital

Dow Jones
·
Jan 23

vTv Therapeutics initiated with a Buy at Roth Capital

TIPRANKS
·
Jan 23

vTv Therapeutics: Late-Stage Cadisegliatin Data, Differentiated Mechanism, and Partnered T2D Expansion Underpin Buy Rating and $40 Target

TIPRANKS
·
Jan 14

TD Cowen Initiates vTv Therapeutics at Buy With $67 Price Target

MT Newswires Live
·
Jan 05

This vTv Therapeutics Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Benzinga_recent_news
·
Jan 05

vTv Therapeutics Initiated at Buy by TD Cowen

Dow Jones
·
Jan 05

vTv Therapeutics Lowers Stockholder Meeting Quorum to 33.4%

Reuters
·
Dec 20, 2025

vTv Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 19, 2025

vTv Therapeutics Inc : H.c. Wainwright Raises Target Price to $47 From $36

THOMSON REUTERS
·
Dec 19, 2025

vTv Therapeutics and M42’s Iros Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health

THOMSON REUTERS
·
Dec 19, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet

Reuters
·
Nov 20, 2025